FDA Reform Tops Spring Work Period Agenda -
The next work period basically runs from April 4 to May 27, with a both chambers adjourning for a week long recess the week of May 2nd. Following this work period, there will...more
Martin Shkreli Not the Big Story on the Hill Last Week -
Congress’s complex relationship with prescription drugs was on display last week in the House of Representatives. In the House Committee on Oversight and...more
2/16/2016
/ Affordable Care Act ,
Biosimilars ,
BPCIA ,
Cancer ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Drug Pricing ,
GDUFA ,
Martin Shkreli ,
Mental Health ,
Prescription Drugs ,
Telemedicine ,
Zika
In This Issue:
- Stakeholders Urge FDA to Provide Clarity on Biosimilars
- Ebola Crisis Continues
- Implementation of the Affordable Care Act
- Other Federal Regulatory Initiatives
- Other...more